Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth. Whatever the consensus opinion may be, our team at StockStory cuts through the noise by conducting independent analysis to determine a company’s long-term prospects. That said, here are two stocks where Wall Street’s pessimism is creating a buying opportunity and one facing legitimate challenges. One Stock to Sell: Intel (INTC) Consensus Price Target: $21.34 (-5.4% implied return) Inventor of the x86 processor that powered decades of technological innovation in PCs, data centers, and numerous other markets, Intel (NASDAQ:INTC) is a leading manufacturer of computer processors and graphics chips. Why Are We Out on INTC? Sales tumbled by 6.9% annually over the last five years, showing market trends are working against its favor during this cycle Overall productivity fell over the last five years as its plummeting sales were accompanied by a decline in its operating margin 25 percentage point decline in its free cash flow margin over the last five years reflects the company’s increased investments to defend its market position Intel’s stock price of $22.55 implies a valuation ratio of 37.5x forward P/E. Read our free research report to see why you should think twice about including INTC in your portfolio, it’s free. Two Stocks to Watch: CrowdStrike (CRWD) Consensus Price Target: $411.55 (-6.3% implied return) Founded by George Kurtz, the former CTO of the antivirus company McAfee, CrowdStrike (NASDAQ:CRWD) provides cybersecurity software that protects companies from breaches and helps them detect and respond to cyber attacks. Why Are We Backing CRWD? Ability to secure long-term commitments with customers is evident in its 29% ARR growth over the last year Projected revenue growth of 21.1% for the next 12 months suggests its momentum from the last three years will persist Robust free cash flow margin of 27% gives it many options for capital deployment At $439.44 per share, CrowdStrike trades at 22.7x forward price-to-sales. Is now the right time to buy? Find out in our full research report, it’s free. Colgate-Palmolive (CL) Consensus Price Target: $98.77 (12.4% implied return) Formed after the 1928 combination between toothpaste maker Colgate and soap maker Palmolive-Peet, Colgate-Palmolive (NYSE:CL) is a consumer products company that focuses on personal, household, and pet products. Why Does CL Stand Out? Economies of scale give it negotiating power with retailers and suppliers as well as fixed cost leverage when sales grow CL is a free cash flow machine with the flexibility to invest in growth initiatives or return capital to shareholders, and its rising cash conversion increases its margin of safety Stellar returns on capital showcase management’s ability to surface highly profitable business ventures, and its returns are climbing as it finds even more attractive growth opportunities Story Continues Colgate-Palmolive is trading at $87.88 per share, or 23.4x forward P/E. Is now a good time to buy? See for yourself in our full research report, it’s free. High-Quality Stocks for All Market Conditions Donald Trump’s victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs. While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 176% over the last five years. Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today for free. View Comments
2 Hated Stocks that Deserve a Second Chance and 1 to Turn Down
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...